Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 75/100

electroCore to Participate at 35th Annual Roth Conference

Thursday, March 9, 2023 1 min read
Key Takeaway: electroCore, Inc. has announced its participation in the 35th Annual Roth Conference scheduled for March 12-14, 2023, in Dana Point, California. Chief Strategy Officer Joshua Lev will engage in a fireside chat during the event. The company also offers opportunities for one-on-one meetings with investors. electroCore focuses on commercializing its non-invasive vagus nerve stimulation technology for health management and wellness.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable industry conference enhances visibility.
  • Opportunity for one-on-one meetings may foster new partnerships.
  • Highlighting innovative non-invasive technology positions the company favorably.

Full Press Release Details

ROCKAWAY, NJ, March 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Strategy Officer, Joshua Lev, will participate in a fireside chat at the 35th Annual Roth Conference in Dana Point, California during March 12-14, 2023.
Date: Tuesday, March 14, 2023
Event: Fireside Chat
electroCore will also be available for one-on-one meetings during the conference. For more information or to schedule a meeting, please visit the conference page here or email Investor Relations at ecor@cg.capital.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Tags

brain injury awareness

Frequently Asked Questions

What is the role of Joshua Lev at electroCore?

Joshua Lev is the Chief Strategy Officer at electroCore.

When is electroCore's participation in the Roth Conference?

electroCore will participate in the Roth Conference from March 12-14, 2023.

What technology does electroCore focus on?

electroCore focuses on non-invasive vagus nerve stimulation (nVNS) technology.

How can investors schedule a meeting with electroCore?

Investors can schedule meetings via the conference page or email Investor Relations.

What markets does electroCore serve?

electroCore serves the U.S. and select overseas markets with its products.

Tags: ECOR Viatris Investor Conferences Healthcare Roth Conference bioelectronic medicine vagus nerve stimulation investor relations
Last updated: Mar 9, 2023